Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/5/2025

Myocardial Bridging and Syncope

Pathophysiology and Clinical Context

  • The European Society of Cardiology identifies that sudden cardiac death typically occurs in males during or after physical activity, and myocardial bridging may lead to syncope through myocardial ischemia-induced arrhythmias, particularly during exercise 1
  • Myocardial bridging occurs in 30-50% of patients with hypertrophic cardiomyopathy and has been implicated as a cause of sudden cardiac death in this population 1, 2

Diagnostic Evaluation

  • The European Heart Association recommends ECG exercise testing, dobutamine stress echocardiography, or myocardial perfusion scintigraphy to evaluate for inducible ischemia in symptomatic patients with myocardial bridging 1, 2, 3
  • Coronary angiography is recommended to visualize the characteristic systolic compression and assess hemodynamic significance 1, 3

Management

  • The European Society of Cardiology recommends beta-blockers as first-line treatment for all symptomatic patients with myocardial bridging, reducing heart rate and decreasing myocardial contractility to reduce systolic compression 1, 2, 3
  • Metoprolol, carvedilol, or bisoprolol are appropriate beta-blocker choices for symptomatic patients with myocardial bridging 3
  • The American College of Cardiology advises against prescribing nitrates for chest pain or syncope in myocardial bridging patients, as they paradoxically worsen systolic compression 1, 2, 3

Special Considerations

  • The American Heart Association notes that asymptomatic competitive athletes with incidental myocardial bridging can participate in all competitive sports without restriction, while symptomatic athletes should restrict participation in high dynamic and static demand sports until symptoms resolve and stress testing normalizes 3
  • The European Society of Cardiology states that there is no evidence supporting activity restriction in asymptomatic individuals without clinical evidence of ischemia 3

REFERENCES

2

Myocardial Bridging: Definition, Clinical Significance, and Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Management of Myocardial Bridging [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025